BSEOthers25 Aug 2026 · 25 Aug 2026, 07:04 pm

Submission of Annual Report for the F.Y. 2025-26

Choksi Laboratories Ltd · 526546

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Choksi Laboratories Ltd - 526546 - Reg. 34 (1) Annual Report.

Attachments (1)

📄

967ff471-34a4-445b-bc5c-f13f2490023d.pdf

pdf

Download →
View document text
Corporate Office & Central Laboratory: Survey No.9/1, Near Tulsiyana Industrial Park, Gram Kumedi-453555 (MP) INDIA Tel: +91 0731-3501112 Email: compliance_officer@choksilab.in Website: www.choksilab.in CIN: L85195MP1993PLC007471 Date: 25th August, 2026 Corporate Relationship Department BSE Limited P.J. Towers, Dalal Street, Mumbai - 400 001 Ref.: Scrip Code – 526546; ISIN – INE493D01013 Subject: Submission of 33rd Annual Report of the Company for F.Y. 2025-2026 pursuant to the provisions of Regulation 34 of SEBI (LODR) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the 33rd Annual Report for the Financial Year 2025-2026 along with Notice of 33rd Annual General Meeting of the Company to be held on Friday, 18th September, 2026 at 12.30 P.M. (IST) through Video Conferencing (“VC”)/Other Audio Visual Means (“OAVM”). Further, in compliance with the relevant Circulars issued by the Ministry of Corporate Affairs, relevant provisions of the Companies Act, 2013 and Securities and Exchange Board of India, the Company is offering facility of remote e-voting and e-voting facility during the AGM to all the shareholders of the Company in respect of the businesses to be transacted at the 33rd AGM. For this purpose, the Company has engaged Central Depository Services (India) Ltd. as its Authorized Agency. The Annual Report for the Financial Year 2025-26 along with the Notice of the 33rd AGM is also available on the website of the Company at www.choksilab.in Kindly take the same on your record and acknowledge. Thanking You Yours faithfully, FOR CHOKSI LABORATORIES LIMITED PRAKHAR DUBEY Company Secretary & Compliance Officer M. No.: A65011 Encl.: 33rd Annual Report along with Notice of AGM for FY. 2025-26 2 0 2 5 - 2 6 Reg. off. Survey No. 9/1, Tulsiyana Industrial Park, Kumerdi, Indore 453555 (M.P.) FROM THE CHAIRMAN’S DESK MESSAGE FROM THE MANAGING DIRECTOR Dear Shareholders, It gives me immense pleasure to present the Annual Report of Choksi Laboratories Limited for the financial year 2025–26. On behalf of the Board of Directors, I extend my sincere gratitude to our shareholders, customers, employees, business associates and all stakeholders for their continued trust and confidence in our Company. The year under review was marked by evolving regulatory requirements, increasing emphasis on quality assurance and a growing demand for reliable analytical testing services across industries. In this dynamic environment, Choksi Laboratories continued to strengthen its position as a trusted provider of comprehensive testing, inspection and analytical solutions. Our unwavering commitment to scientific excellence, technical competence and customer satisfaction enabled us to deliver accurate, reliable and timely services across pharmaceuticals, food & beverages, water, environmental monitoring, agriculture, chemicals, petroleum products, construction materials and allied sectors. During the year, we continued to enhance our laboratory capabilities through investments in advanced analytical instruments, digital technologies and technical expertise. Our focus remained on strengthening operational efficiency, improving turnaround time and ensuring compliance with national and international quality standards. These initiatives have further reinforced our ability to meet the evolving requirements of our customers while maintaining the highest standards of integrity, KEY TESTING SECTORS precision and reliability. We are committed to continuously upgrading our Pharmaceuticals infrastructure, expanding our service portfolio and adopting emerging technologies that enhance analytical accuracy and operational excellence. Our emphasis on Food & Beverages research, quality assurance and continual improvement enables us to create long- Water Testing term value for our customers and stakeholders. Environmental Monitoring As a responsible corporate citizen, we remain committed to sustainable business Agriculture practices. Through responsible resource utilization, environmentally conscious Chemicals laboratory operations and adherence to ethical business principles, we continue to contribute towards a safer, healthier and more sustainable future. We believe that Petroleum Products sustainable growth can only be achieved through responsible governance, Construction Materials environmental stewardship and social responsibility. The achievements of the Company would not have been possible without the dedication, professionalism and commitment of our employees. I sincerely appreciate the efforts of our talented team whose expertise and passion continue to drive the Company's success. I also express my gratitude to our customers, business partners, regulatory authorities and shareholders for their unwavering support and confidence. Looking ahead, we remain optimistic about the opportunities within the analytical testing industry. With increasing awareness regarding product quality, regulatory STRATEGIC PRIORITIES 1. Leadership in analytical testing compliance and environmental sustainability, the demand for reliable laboratory services is expected to grow steadily. Choksi Laboratories Ltd is well positioned to & lab services. capitalize on these opportunities through technological advancement, customer- 2. Advanced instrumentation & centric solutions and operational excellence. digital transformation. 3. Expanding service offerings for Together, we will continue our journey of scientific excellence, operational market demand. integrity and sustainable growth while contributing meaningfully towards improving public health, environmental protection and industrial quality 4. Upholding quality, compliance standards. & governance. 5. Creating sustainable long-term Thank you for your continued trust and support. value. Warm Regards, Sunil Choksi Managing Director • Choksi Laboratories Limited 33rd ANNUAL REPORT 2025-26 CHOKSI LABORATORIES LIMITED Company Information CIN : L85195MP1993PLC007471 COMPOSITION OF BOARD Mr. Sunil Choksi - Managing Director& Chairman Mrs. Stela Choksi - Whole Time Director Ms. Himika Choksi - Whole Time Director Mr. Vyangesh Choksi - Whole Time Director Independent Directors: Mrs. Abha Shastri - Independent Director Mr. Raghmendra Singh - Independent Director Mr. Ritik Pavecha - Independent Director Mrs. Prachi Mantri - Independent Director KEY MANAGERIAL PERSONNEL Mrs. Stela Choksi - Chief Financial Officer Mr. Prakhar Dubey - Company Secretary & Compliance Officer STATUTORY AUDITORS REGISTERED OFFICE & CENTRAL Prateek Jain & Co., LAB: Chartered Accountants Survey No.9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, Indore - 453555. SECRETARIAL AUDITORS (Madhya Pradesh) Surabhi Agrawal & Associates Company Secretaries OUR BRANCHES LABORATORIES REGISTRAR & SHARE TRANSFER 1. 32, Vibrant Business Park, Opp. UPL, AGENT N.H-48 Vapi – 369195 (Gujarat) Ankit Consultancy Private Limited 60, Electronic Complex, Pardeshipura, 2. 829, GIDC Makarpura, Vadodara - Indore (M.P.) 452010 390010 (Gujarat) BANKERS 3. Plot No. C-18 & 20 Phace 1 - A, Verna State Bank of India & HDFC Bank Industrial Estate Verna (Goa)- 403722 4. Plot No. 198, Industrial Area Phase II, Listed On: Bombay Stock Exchange Panchkula (Haryana) - 134113 CHOKSI LABORATORIES LIMITED NOTICE OF 33rd ANNUAL GENERAL MEETING Notice is hereby given that the 33rd Annual General Meeting of the members of Choksi Laboratories Limited is scheduled to be held on Friday, 18th September, 2026 at 12.30 P.M. through Video Conferencing (“VC”) or Other Audio-Visual Means (“OAVM”) for which purpose the Registered Office of the company shall be deemed as the venue for the Meeting and the proceedings of the Annual General Meeting shall be deemed to be made there at, to transact the following businesses: ORDINARY BUSINESS: 1. To approve Audited Financial Results for the Year ended March 31, 2026 togethe [Showing first 8,000 characters — download PDF for full document]